Other: Ketogenic Diet ( DrugBank: - )

---

2 diseases

ID	Disease name (Link within this page)	Number of trials
19	Lysosomal storage disease	1
67	Polycystic kidney disease	1

19. Lysosomal storage disease

---

Clinical trials : 854 /  Drugs : 716 - (DrugBank : 105) / Drug target genes : 70 - Drug target pathways : 191

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02030015 (ClinicalTrials.gov)	December 22, 2015	17/12/2013	Synergistic Enteral Regimen for Treatment of the Gangliosidoses	Synergistic Enteral Regimen for Treatment of the Gangliosidoses (Syner-G)	GM1 Gangliosidoses;GM2 Gangliosidoses;Tay-Sachs Disease;Sandhoff Disease	Drug: miglustat;Other: Ketogenic Diet	University of Minnesota	Rare Diseases Clinical Research Network;National Center for Advancing Translational Science (NCATS);National Institute of Neurological Disorders and Stroke (NINDS);National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK);Lysosomal Disease Network	Recruiting	N/A	204 Months	All	30	Phase 4	United States

67. Polycystic kidney disease

---

Clinical trials : 216 /  Drugs : 219 - (DrugBank : 50) / Drug target genes : 39 - Drug target pathways : 151

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04680780 (ClinicalTrials.gov)	January 10, 2021	1/10/2020	Ketogenic Dietary Interventions in Autosomal Dominant Polycystic Kidney Disease (ADPKD)	Ketogenic Dietary Interventions in Autosomal Dominant Polycystic Kidney Disease (ADPKD)	ADPKD	Other: Ketogenic diet;Other: 3-days water-fasting;Other: Control	University of Cologne	NULL	Active, not recruiting	18 Years	60 Years	All	63	N/A	Germany